glp 1 and gip medication GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica How Three Types of GLP-1

It is suggested that it promotes angiogenesis, which is the formation of new blood vessels

Its oral small-molecule design improves accessibility and patient compliance compared to injectables

This included Matthias Tschp (figure 39), a German who completed a medical degree at Ludwig Maximilian University of Munich in 1993 and then worked as a clinician in neuroendocrinology before taking up a research fellowship at Eli Lilly Discovery Research Laboratories in 1999 to gain expertise in drug discovery and development

I would advise people take very seriously their willingness to deal with long term side effects and complications of these medications